InMode (INMD) Total Non-Current Liabilities (2018 - 2026)
InMode (INMD) posted quarterly Total Non-Current Liabilities of $12.2 million for Q1 2026, down 3.3% year-on-year from $12.6 million in Q1 2025, and down 2.05% on a QoQ basis from $12.5 million in Q4 2025.
InMode (INMD) Total Non-Current Liabilities (2018 - 2026) Analysis & Trends
InMode (INMD) has reported Total Non-Current Liabilities for 9 consecutive years, with $12.2 million the latest figure, recorded in Q1 2026.
- Quarterly Total Non-Current Liabilities fell 3.3% year-over-year to $12.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.2 million (down 3.3% YoY) and the FY2025 annual result came in at $12.5 million, up 4.03% from the prior year.
- Total Non-Current Liabilities fell to $12.2 million in Q1 2026 per INMD's latest filing, from $12.5 million in the prior quarter.
- Over the last five years, Total Non-Current Liabilities for INMD reached as high as $13.4 million in Q2 2025 and fell as low as $7.0 million in Q1 2023.
- A 5-year average of $11.0 million and a median of $11.8 million in 2023 frame the typical range for Total Non-Current Liabilities.
- Annual changes were most pronounced in 2022 — Total Non-Current Liabilities surged 64.94% — and 2023, when it tumbled 42.0%.
- Year by year, Total Non-Current Liabilities stood at $7.8 million in 2022, then surged by 51.56% to $11.8 million in 2023, then rose by 1.91% to $12.0 million in 2024, then advanced by 4.03% to $12.5 million in 2025, then decreased by 2.05% to $12.2 million in 2026.
- According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $12.2 million, $12.5 million, and $12.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 41.44 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 41.88 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 2.64 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 3.53 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 9.85 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 3.57 Bn |
| 10 | InMode | 956,721.10 | -479.17 Mn | 61.55 Mn | 12.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.23 Mn |
| Dec 31, 2025 | 12.49 Mn |
| Sep 30, 2025 | 12.89 Mn |
| Jun 30, 2025 | 13.38 Mn |
| Mar 31, 2025 | 12.65 Mn |
| Dec 31, 2024 | 12.00 Mn |
| Sep 30, 2024 | 11.44 Mn |
| Jun 30, 2024 | 11.03 Mn |
| Mar 31, 2024 | 11.31 Mn |
| Dec 31, 2023 | 11.78 Mn |
| Sep 30, 2023 | 7.85 Mn |
| Jun 30, 2023 | 7.19 Mn |
| Mar 31, 2023 | 6.96 Mn |
| Dec 31, 2022 | 7.77 Mn |
| Sep 30, 2022 | 12.75 Mn |
| Jun 30, 2022 | 12.40 Mn |
| Mar 31, 2022 | 11.33 Mn |
| Dec 31, 2021 | 10.89 Mn |
| Sep 30, 2021 | 9.76 Mn |
| Jun 30, 2021 | 9.68 Mn |